comprehensive -WSS

comprehensive

author：leisure time 2025-09-27 09:38:04 - browse：9

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated.

That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT. Kassum confirmed around 75% of Celsius’ 40-person team had been laid off, and disclosed that the biotech has also been quietly paring back its pipeline this year. It shut down almost all early-stage research projects, including pausing all of its cancer drug work, in order to conserve enough cash for the Phase 1 trial it announced this week.

“It’s an incredibly bittersweet moment.… The cognitive dissonance there is just really, really hard,” Kassum told STAT. “But I do think that you’re seeing a lot of other companies doing what we are, which is, as painful as it is, to focus on the nearest term value drivers, the things that can get to patients the quickest, and make the painful decisions that allow you to live to fight another day.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Primary care physicians play key roles in Alzheimer's management

focus

WSS

Oprah kicked off a national conversation on obesity. Let's have it

Biden administration sends mixed signals on US soldier who crossed into North Korea

Why the world’s most expensive drug might be worth the price

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Johnson & Johnson sues to stop Medicare negotiation

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

hotspot

comprehensive

focus

Affirmative action in medical school literally saved lives

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

State Dept. review finds Biden bears some blame for Afghanistan failures

Food as medicine: Medically tailored meals may get standardized

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: Merck, Vertex, and Viking updates

Trump demands the U.S. pay no more for drugs than other countries … again

US soldier in North Korean custody after crossing DMZ line

Bright Health sells Medicare Advantage business to Molina

ER docs worry over extreme heat as a 'mass casualty event'

entertainment

Eliminate the waiting period for sterilization covered by Medicaid

Abortion pill case raises question: who can sue the FDA?

Washington mulls new rules to avert another Change Healthcare

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Lack of darker skin in textbooks, journals harms patients of color

Biden administration sends mixed signals on US soldier who crossed into North Korea

focus

entertainment

hotspot

focus